Bicycle Therapeutics Statistics

Total Valuation

BCYC has a market cap or net worth of $511.41 million. The enterprise value is -$358.62 million.

Market Cap	511.41M
Enterprise Value	-358.62M

Important Dates

The next estimated earnings date is Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

BCYC has 69.20 million shares outstanding. The number of shares has increased by 63.54% in one year.

Current Share Class	n/a
Shares Outstanding	69.20M
Shares Change (YoY)	+63.54%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	1.41%
Owned by Institutions (%)	41.87%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.19
Forward PS	17.74
PB Ratio	0.64
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.81, with a Debt / Equity ratio of 0.01.

Current Ratio	13.81
Quick Ratio	13.61
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-121.31

Financial Efficiency

Return on equity (ROE) is -29.04% and return on invested capital (ROIC) is -21.53%.

Return on Equity (ROE)	-29.04%
Return on Assets (ROA)	-16.90%
Return on Invested Capital (ROIC)	-21.53%
Return on Capital Employed (ROCE)	-23.59%
Revenue Per Employee	$115,656
Profits Per Employee	-$554,200
Employee Count	305
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	-4.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.48% in the last 52 weeks. The beta is 1.40, so BCYC's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-66.48%
50-Day Moving Average	9.71
200-Day Moving Average	18.14
Relative Strength Index (RSI)	40.28
Average Volume (20 Days)	438,943

Short Selling Information

Short Interest	4.30M
Short Previous Month	4.40M
Short % of Shares Out	9.73%
Short % of Float	n/a
Short Ratio (days to cover)	12.75

Income Statement

In the last 12 months, BCYC had revenue of $35.28 million and -$169.03 million in losses. Loss per share was -$2.90.

Revenue	35.28M
Gross Profit	-137.69M
Operating Income	-209.87M
Pretax Income	-163.02M
Net Income	-169.03M
EBITDA	-202.70M
EBIT	-209.87M
Loss Per Share	-$2.90

Full Income Statement

Balance Sheet

The company has $879.52 million in cash and $9.49 million in debt, giving a net cash position of $870.03 million or $12.57 per share.

Cash & Cash Equivalents	879.52M
Total Debt	9.49M
Net Cash	870.03M
Net Cash Per Share	$12.57
Equity (Book Value)	793.06M
Book Value Per Share	11.48
Working Capital	861.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$164.72 million and capital expenditures -$1.24 million, giving a free cash flow of -$165.96 million.

Operating Cash Flow	-164.72M
Capital Expenditures	-1.24M
Free Cash Flow	-165.96M
FCF Per Share	-$2.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-594.96%
Pretax Margin	-492.69%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCYC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-63.54%
Shareholder Yield	n/a
Earnings Yield	-33.05%
FCF Yield	-32.45%

Analyst Forecast

The average price target for BCYC is $29.14, which is 296.46% higher than the current price. The consensus rating is "Buy".

Price Target	$29.14
Price Target Difference	296.46%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	72.50%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BCYC has an Altman Z-Score of 4.12 and a Piotroski F-Score of 3.

Altman Z-Score	4.12
Piotroski F-Score	3